Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Nursing & Clinical Practices Volume 3 (2016), Article ID 3:IJNCP-211, 6 pages
https://doi.org/10.15344/2394-4978/2016/211
Research Article
Attention of Cancer Care for Totally Implantable Venous-access Ports Associate Complications the Latest 6 Years Analysis of 400 Cancer Chemotherapy Patients

Hiroshi Osawa1*, Yoshie Takazawa2, Tamayo Kameoka2, Ryoko Yanai2 and Chie Hirosawa2

1Department of Oncology and Hematology, Edogawa Hospital, Tokyo, Japan
2Department of Nursing, Edogawa Hospital, Tokyo, Japan
Dr. Hiroshi Osawa, Department of Oncology and Hematology, Edogawa Hospital, 2-24-18 Higashi-koiwa, Edogawa-ku, Tokyo 133-0052, Japan; E-mail: oosawa@edogawa.or.jp
12 October 2016; 28 November 2016; 30 November 2016
Osawa H, Takazawa Y, Kameoka T, YanaiR, Hirosawa C (2016) Attention of Cancer Care for Totally Implantable Venous-access Ports Associate Complications the Latest 6 Years Analysis of 400 Cancer Chemotherapy Patients. Int J Nurs Clin Pract 3: 211. doi: https://doi.org/10.15344/2394-4978/2016/211
© 2016 Osawa et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Kurul S, Saip P, Aydin T (2002) Totally implantable venous-access ports: local problems and extravasation injury. The Lancet OncolVol 3: 684-692 [CrossRef] [Google Scholar] [PubMed]
  2. Taniguchi K, Oka K, Tokuyasu N, Naka T, Kondo T, et al. (2008) Clinical outcome of totally implantable subcutaneous infusion port--comparison with home parenteral nutrition and chemotherapy. Gan To Kagaku Ryoho 35: 281-285 [Google Scholar] [PubMed]
  3. Sakamoto E, Hasegawa H, Komatsu S, Norimizu S, Shingu Y, et al. (2013) [Complications after implantation of subcutaneous central venous port]. Gan To Kagaku Ryoho 40: 613-616 [Google Scholar] [PubMed]
  4. Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, et al. (1999) Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 9:767-773 [CrossRef] [Google Scholar] [PubMed]
  5. Nishihara K, Wolosker N, Bernardi CV,Yazbek G (2010) Totally implantable ports connected to valved catheters for chemotherapy: experience from 350 Groshong devices. J Vasc Access 11:17-22 [CrossRef] [Google Scholar] [PubMed]
  6. Lam AW, Chen YM, Yang KY, Tsai CM, Perng RP (1999) Disconnection of a venous Port-A-Cath followed by embolization after saline flush: rare case report. Jpn J Clin Oncol 29: 643-645 [CrossRef] [Google Scholar] [PubMed]
  7. Klotz HP, Schöpke W, Kohler A, Pestalozzi B, Largiadèr F (1996) Catheter fracture: a rare complication of totally implantable subclavian venous access devices. J Surg Oncol 62: 222-225 [CrossRef] [Google Scholar] [PubMed]
  8. Di Carlo, Fisichella P, Russello D, Puleo S, Latteri F (2000) Catheter fracture and cardiac migration: a rare complication of totally implantable subclavian venous access devices. J Surg Oncol 73: 172-173 [CrossRef] [Google Scholar]
  9. Koch HJ, Pietsch M, Krause U, Wilke H, Eigler FW (1998) Implantable venous access system: experience in 1500 patients with totally implanted central venous port system. World J Surg 22: 12-16 [CrossRef] [Google Scholar] [PubMed]
  10. Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, et al. (2001) A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 92: 1204-1212 [CrossRef] [Google Scholar] [PubMed]
  11. Chenga CC, Tasa TN, Yang CC, Han CL (2009) Percutaneous retrieval of dislodged totally implantable central venous access system in 92 cases: Experience in a single hospital. Eur J Radiol 69: 346-350 [CrossRef] [Google Scholar] [PubMed]
  12. Haindl H (1989) Technical complications of port-catheter systems. Reg Cancer Treat2:238-242
  13. Schwarz RE, Groeger J, Coit DG (1997) Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 79: 1635-1650 [CrossRef] [Google Scholar] [PubMed]
  14. Viale PH, Yamamoto DS, Geyton JE (1999) Extravasation of infusate via implanted ports: two case studies. Clin J Oncol Nurs 3: 145-151 [Google Scholar] [PubMed]
  15. Bow EJ, Kilpatrick G, Clinch JJ (1999) Totally implantable venous ports system for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J ClinOncol 17: 1267-1273 [CrossRef] [Google Scholar] [PubMed]
  16. Walsh-McMonagle D, Green D (1997) Low-molecular-weight heparin in the management of Trousseau's syndrome. Cancer 80: 649-655 [CrossRef] [Google Scholar] [PubMed]
  17. Uchiyama S (2008) Paraneoplastic neurological syndromes: Trousseau syndrome. Nihon Naika Gakkai Zasshi 10: 1805-1808 [Google Scholar] [PubMed]
  18. Haire WD, Lieberman RP, Edney J, Vaughan WP, Kessinger A, et al. (1990) Hickman catheter-induced thoracic vein thrombosis. Frequency and longterm sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer 66: 900-908 [CrossRef] [Google Scholar] [PubMed]
  19. Yung B, Elborn JS, Campbell IA, Summers Y, Beckles M, et al. (1997) Thromboembolism related to a Port-a-Cath device in a patient with cystic fibrosis. Thorax 52: 98-99 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.